Literature DB >> 2730264

Hyperviscosity syndrome in a patient with acquired immunodeficiency syndrome.

C M Martin1, A G Matlow, E Chew, D Sutton, W Pruzanski.   

Abstract

The hyperviscosity syndrome is most commonly seen in association with monoclonal gammopathies and has only rarely been described in association with polyclonal hypergammaglobulinemia. We have recently seen a patient with known acquired immunodeficiency syndrome who presented with the hyperviscosity syndrome in the setting of polyclonal hypergammaglobulinemia. To our knowledge, this is the first reported case of a patient with the acquired immunodeficiency syndrome and the hyperviscosity syndrome. The case is presented and the pathogenesis and implications of this diagnosis are discussed.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2730264

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


  2 in total

Review 1.  Adverse effects of intravenous immunoglobulin therapy.

Authors:  U E Nydegger; M Sturzenegger
Journal:  Drug Saf       Date:  1999-09       Impact factor: 5.606

2.  Hyperviscosity in HIV infected children--a potential hazard during intravenous immunoglobulin therapy.

Authors:  R A Hague; O B Eden; P L Yap; J Y Mok; P Rae
Journal:  Blut       Date:  1990 Aug-Sep
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.